News
-
Access Consortium’s Advanced Therapy Medicinal Products Working Group
-
First electronic product information (ePI) published for selected human medicines
-
The differentiated regulation of hemp products should be maintained
-
Operation Pangea XVI: International campaign against falsified and illegally imported medicinal products
-
Revision of the Ordinance on Medical Devices (MedDO) and Ordinance on In Vitro Diagnostic Medical Devices (IvDO)
-
Swissmedic confirmed as World Health Organization Listed Authority
-
Medicinal products review – The Federal Office of Public Health reduces prices
-
The European Medicines Agency (EMA) takes further steps to address critical shortages of medicines in the European Union
-
National Strategy on Addiction: Measures against online addiction are sufficient
-
New cost containment measures will come into effect on 1 January 2024
-
European Medicines Agency (EMA) takes further steps to address critical shortages of medicines in the EU
-
The army pharmacy is supplying the population with iodine tablets
-
Amendments to the Ordinance on Health Insurance: Opening of the consultation procedure
-
Swissmedic reviewed Swiss importers
-
New treatment option for heavily pre-treated multiple myeloma patients
-
The flu vaccination season begins
-
Health risks of designer drugs: further psychoactive substances prohibited
-
Swissmedic Journal 09/2023
-
Counterfeit Ozempic diabetes medication in circulation
-
Revised transparency rules for the EU Clinical Trials Information System
-
The dispute over the CRISPR-Cas9 basic patents